Strategies to assess and manage hypervolemia The invisible threat in dialysis
|
|
- Myron Bates
- 5 years ago
- Views:
Transcription
1 Strategies to assess and manage hypervolemia The invisible threat in dialysis Rajiv Agarwal MD Professor of Medicine, Indiana University School of Medicine
2 Volume excess is common and costly. Admission for CHF in dialysis: 22% per year Volume overload needing acute dialysis: 14% per year Cost to Medicare (over 2.5 years): $266 million USRDS 2009 Annual Data Report Arneson TJ, et al. Clin J Am Soc Nephrol, 2010
3 HTN Volume Overload LVH CV Events Agarwal R, et al. Am J Med 115: , 2003 Sarnak MJ, et al. Circulation 108: , 2003 USRDS 2009 Annual Data Report Lazarus JM, et al. Arch Intern Med 133: , 1974 Wizemann V, et al. Nephrol Dial Transplant 24: , 2009 Agarwal R. Hypertension 56: , 2010 MORTALITY
4 The challenge of assessing volume diagnosing hypervolemia
5 Seven methods to assess volemia History and examination Direct measurement of total body water Natriuretic peptides Bioimpedance analysis Relative plasma volume monitoring Blood pressure monitoring Echocardiogram
6 Seven methods to assess volemia History and examination Direct measurement of total body water Natriuretic peptides Bioimpedance analysis Relative plasma volume monitoring Blood pressure monitoring Echocardiogram
7
8 Pedal edema is not a volume marker Pedal edema is not associated with: IVC diameter BNP Relative plasma volume Inflammation markers Agarwal R, et al CJASN 3: 153, 2008
9 Odds ratio of Pedal Edema in HD Pedal edema associates with obesity, age, and LVH BMI <25 kg/m2 (Normal or Underweight) BMI 25 to 29.9 kg/m2 (Overweight) BMI >30 kg/m2 (Obese) LV mass < median (68.8 g/m2.7) LV mass median (68.8 g/m2.7) Agarwal R, et al CJASN 3: 153, 2008
10 Seven methods to assess volemia History and examination Direct measurement of total body water Natriuretic peptides Bioimpedance analysis Relative plasma volume monitoring Blood pressure monitoring Echocardiogram
11
12 Volume of distribution of alcohol = TBW
13 Drawbacks Several hours for measurement Alcohol exposure No data on how to use this information
14
15
16
17 Seven methods to assess volemia History and examination Direct measurement of total body water Natriuretic peptides Bioimpedance analysis Relative plasma volume monitoring Blood pressure monitoring Echocardiogram
18
19 In the DRIP trial, BNP did not Decline more with ultrafiltration Associate with more weight loss Associate with a greater improvement in interdialytic ambulatory BP
20 Seven methods to assess volemia History and examination Direct measurement of total body water Natriuretic peptides Bioimpedance analysis Relative plasma volume monitoring Blood pressure monitoring Echocardiogram
21 R ECW Adjusted for Bone Mineral Content R ECW Adjusted for Lean Body Mass Whole body BIA can detect changes in ECW Pre-HD Post-HD Pre-HD Post-HD Fisch BJ et al., Kidney Int 49: 1105, 1996
22 Resistance (ohms) Segmental resistance increases with UF-dialysis Pre-HD Post-HD Arm Trunk Leg Zhu F et al, ASAIO Journal 44: M541, 1998
23 Does BIA-guided dry-weight management result in better BP, TOD, outcomes? No study so far
24 Seven methods to assess volemia History and examination Direct measurement of total body water Natriuretic peptides Bioimpedance analysis Relative plasma volume monitoring Blood pressure monitoring Echocardiogram
25 Blood Volume Monitoring
26 Disposable Blood Chamber
27 Sensor Clip
28 Liquid Crystal Display
29 Full Assembly
30 RPV Principle Euvolemic Vascular Refill Increasing Hemo- Concentration Ultrafiltration Interstitial Space Vascular Space
31 Relative Plasma Volume (%) RPV Tracing Time on Dialysis (hrs)
32 RPV Principle Hypervolemic Vascular Refill No Hemo- Concentration Ultrafiltration Interstitial Space Vascular Space
33 Relative Plasma Volume (%) RPV Tracing Time on Dialysis (hrs)
34 Relative Plasma Volume (%) RPV Tracing Time on Dialysis (hrs)
35 RPV and Volemia Pre-specified secondary analysis of 150 HD patients in DRIP Trial
36 DRIP Trial Ambulatory BP RPV monitoring 150 patients 2 weeks On dialysis 3 months Ambulatory BP 135/85 8 weeks 100 patients ultrafiltration group Randomized 50 patients control group 8 weeks RPVM RPVM ABP ABP Agarwal R, et al. Hypertension 53: , 2009
37 Study overview Design: Diagnostic test study Test: RPV monitoring Comparison standards of volume state: 1. Change in RPV slope 2. Ambulatory BP change
38 Relative Plasma Volume (%) Modeled RPV Slopes Control Group Baseline Final Ultrafiltration Group Baseline Final 94 P < Time on Dialysis (hrs) Sinha AD, et al. Hypertension 55: , 2010
39 Change in Ambulatory BP (mmhg) Control Corrected Change in Ambulatory BP in Ultrafiltration Group P < (steepest) 2 3 Quartile of RPV Slope 4 (flattest) Sinha AD, et al. Hypertension 55: , 2010
40 Participants surviving (%) Ultrafiltration volume not predictive of mortality Months since randomization Number at risk Higher UF Volume Lower UF Volume UF vol >2.7L UF vol <2.7L Logrank p = Agarwal R, Hypertension 56: 512, 2010
41 Participants surviving (%) But flatter RPV slopes associated with a higher mortality Number at risk Flatter slope Steeper slope Flatter Steeper Logrank p = Months since randomization Agarwal R, Hypertension 56: 512, 2010
42 Hazard Ratio for death Relative plasma volume is independently associated with mortality 3 2,5 2 1,5 Adjusted (age, sex, race, CVD, BP meds, dialysis vintage, albumin, Hgb) Adjusted + UF volume Adj + UFR Adj + UFR/kg Adj + UFR/kg + ABPM 1 0,5 0 p=0.02 p=0.008 p=0.002 p=0.001 P<0.001 Progessively Adjusted Models Agarwal R, Hypertension 56: 512, 2010
43 Does RPV-guided dry-weight management result in better BP, TOD, or outcomes?
44 RPV Monitoring Randomized Clinical Trial Crit-Line Intradialytic Monitoring Benefit (CLIMB) Study Multicenter trial with 6 centers in the U.S. and Canada Reddan DN, et al. J Am Soc Nephrol 16: , 2005
45 CLIMB Study RPVM 6 months RPV monitoring 227 patients RPVM group 443 patients 2 weeks On dialysis 2 months Randomized 216 patients control group 6 months RPVM Reddan DN, et al. J Am Soc Nephrol 16: , 2005
46 CLIMB Results RR for non-access related admit in RPVM group 1.49 (P = 0.017) Mortality 8.7% in RPVM group vs. 3.3% for control (P = 0.021) Reddan DN, et al. J Am Soc Nephrol 16: , 2005
47 However Algorithm use was encouraged, but not mandated Highly variable implementation of the monitoring and interventional algorithm occurred within and across dialysis units. Reddan DN, et al. J Am Soc Nephrol 16: , 2005
48 Control Group RPV Slope Baseline Distribution Steep 8% Flat 32% 60% Intermediate Reddan DN, et al. J Am Soc Nephrol 16: , 2005
49 Control Group RPV Slope Final Distribution Steep 11% Flat 23% 65% Intermediate Reddan DN, et al. J Am Soc Nephrol 16: , 2005
50 % of Patients with RPV slope Control group has fewer patients with flat slopes despite no intervention! 100% 80% % 40% Flat Intermed Steep 20% 0% Baseline 6 Months Baseline 6 Months Control Intervention Reddan DN, et al. J Am Soc Nephrol 16: , 2005
51 Does RPV-guided dry-weight management result in better BP, TOD, or outcomes? Don t know, we need a better study!
52 Seven methods to assess volemia History and examination Direct measurement of total body water Natriuretic peptides Bioimpedance analysis Relative plasma volume monitoring Blood pressure monitoring Echocardiogram
53 Systolic Home BP of >150 mm Hg has a sensitivity of 80% and specificity of 84% in diagnosing interdialytic ambulatory hypertension AUC Home BP Agarwal R, et al. Kidney Int 69: , 2006
54 Is out of dialysis unit BP of prognostic value? Baseline cohort followed for 2 years for all-cause mortality. 46 patients (31%) died. Quartiles of systolic BP associated with mortality in a Cox model. Alborzi P et al CJASN 2:1228, 2007
55 Hazard Ratio of All Cause Mortality Out of dialysis unit BP are of greater prognostic significance Q1 Q2 Q3 Q4 Best home BP mm Hg P=0.05 P=0.011 Best ABP mm Hg 2 P=0.999 P=0.182 P=0.228 P= PreHD Routine Post HD Routine PreHD Standardized Post HD Standardized Home Ambulatory Alborzi P et al CJASN 2:1228, 2007
56 Does Home BP-guided BP management result in better BP, TOD, outcomes?
57 Home BP in HD Trial Design Home BP Group (n=34) Hypertension + Hemodialysis R Adjust antihypertensive medications Adjust antihypertensive medications 24-hr Ambulatory Blood Pressure + Echocardiogram Dialysis Unit Group (n=31) 0 6 months ABPM Echocard ABPM Echocard Da Silva GV, et al NDT 2009 doi: /ndt/gfp332
58 24 hour ambulatory Systolic BP (mmhg) RCT shows that ambulatory BP improves with the use of home BP monitoring Dialysis Unit Gp Home BP Gp BL 6 mo No change seen on echo LVH Da Silva GV, et al NDT 2009 doi: /ndt/gfp332
59 Seven methods to assess volemia History and examination Direct measurement of total body water Natriuretic peptides Bioimpedance analysis Relative plasma volume monitoring Blood pressure monitoring Echocardiogram
60 IVC Diameter End Expiration 1.89 cm = 10.5 mm/m 2
61 IVC Diameter End Inspiration 1.83 cm CI = 3.1%
62
63 Lung comets by ultrasound
64 Lung comets Jambrik Z et al. Am J Cardiol 93: 1265, 2004
65 Lung comets marker of pulmonary congestion correlated with ACM + cardiac events
66 What can you do today? Be aware of occult hypervolemia. Ask yourself the question: could these symptoms be due to hypervolemia? If discharged from the hospital, probe dry weight. If BP runs low and the patient is repeatedly hospitalized due to pneumonia, probe dry weight If home BP is high, probe dry weight Technology is unreliable, but RPV is the tool I use as my eyes to volume. Prescribe at least 4 hours of dialysis. If they cut their time or miss dialysis, they are likely not euvolemic. Root cause analysis: transportation, child-care, cramps etc Engage the dietitian, social worker, spouse, the patient to dialyze adequately.
67 Take home message Dialysis is not just about Kt/V, Hgb, Phos. Volume is important. We CAN do better!
Achieve. Achieve. More Effective. Dialysis Treatment
Achieve More Effective Achieve Dialysis Treatment The Crit-Line monitor measures the following: Real-time, lab-equivalent, non-invasive hematocrit (HCT) Real-time percent changes in intravascular blood
More informationCrit-Line Monitor. Frequently Asked Questions
Crit-Line Monitor Frequently Asked Questions Crit-Line Monitor Frequently Asked Questions 1 What is the indication for use of the Crit-Line monitor? The Crit-Line Monitor III is used to non-invasively
More informationAlthough the adequacy of solute clearance in patients on
Relative Plasma Volume Monitoring During Hemodialysis Aids the Assessment of Dry Weight Arjun D. Sinha, Robert P. Light, Rajiv Agarwal Downloaded from http://hyper.ahajournals.org/ by guest on May 2, 2018
More informationFLUID MANAGEMENT IN DIALYSIS: STRATEGIES FOR SUCCESS
FLUID MANAGEMENT IN DIALYSIS: STRATEGIES FOR SUCCESS Quality Insights Renal Network 3 October 2, 2014 Laura D. Byham-Gray, PhD, RD Professor & Director Master of Science in Clinical Nutrition Rutgers University
More informationIntradialytic hypertension is a marker of volume excess
Nephrol Dial Transplant (2010) 1 of 6 doi: 10.1093/ndt/gfq210 NDT Advance Access published April 16, 2010 Original Article Intradialytic hypertension is a marker of volume excess Rajiv Agarwal 1,2 and
More informationMaher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University
Hypertension in Hemodialysis Patient Maher Fouad Ramzy; MD, FACP Professor of Renal Medicine, Cairo University Mechanism of HTN in HD patients Volume-dependent HTN ECV expansion. Volume-independent HTN
More informationStriking the Optimal Balance in
Not Too fast, Not Too Slow: Striking the Optimal Balance in Hemodialysis Fluid Management ANNA/ IPRO Spring Symposium May 24, 2018 Jennifer E. Flythe, MD, MPH Assistant Professor of Medicine University
More informationInnovations in Cardio/Renal Patient Care. Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health at San Antonio Spring Symposium 2018
Innovations in Cardio/Renal Patient Care Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health at San Antonio Spring Symposium 2018 Percent of Patients CVD = cardiovascular disease; ASHD =
More informationHow is the dialysis patient different?
How is the dialysis patient different? Mihály Tapolyai, MD, FASN, FACP Fresenius Medical Care SOTE, Budapest; Hungary Minneapolis VAMC, Minneapolis, MN; USA How is the dialysis patient different? Dialysis
More informationHTA ET DIALYSE DR ALAIN GUERIN
HTA ET DIALYSE DR ALAIN GUERIN Cardiovascular Disease Mortality General Population vs ESRD Dialysis Patients 100 Annual CVD Mortality (%) 10 1 0.1 0.01 0.001 25-34 35-44 45-54 55-64 66-74 75-84 >85 Age
More informationHaemodiafiltration - the case against. Prof Peter G Kerr Professor/Director of Nephrology Monash Health
Haemodiafiltration - the case against Prof Peter G Kerr Professor/Director of Nephrology Monash Health Know your opposition.. Haemodiafiltration NB: pre or post-dilution What is HDF how is it different
More informationDialysis outcomes: can we do better?
Dialysis outcomes: can we do better? Allan J. Collins, MD, FACP Professor of Medicine University of Minnesota Director, Chronic Disease Research Group Minneapolis Medical Research Foundation Director,
More informationFluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)
Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI) Robert W. Schrier, MD University of Colorado School of Medicine Denver, Colorado USA Prevalence of acute renal failure in Intensive
More informationAchieving Equilibrium in ESRD Patients
Achieving Equilibrium in ESRD Patients -Marc Richards MD -South Florida Kidney Disease and HTN Specialists -Chief of Medicine, BRRH -BRRH Grand Rounds: April 18 th, 2017 Outline Dialysis prescription Adequacy
More information02/28/2018. To reduce morbidity, mortality and treatment loss associated with chronic volume overload in hemodialysis patients
Lisa Koester Renal Nurse Practitioner Washington University School of Medicine St. Louis, MO To reduce morbidity, mortality and treatment loss associated with chronic volume overload in hemodialysis patients
More informationBlood Pressure Monitoring in Chronic Kidney Disease
Blood Pressure Monitoring in Chronic Kidney Disease Aldo J. Peixoto, MD FASN FASH Associate Professor of Medicine (Nephrology), YSM Associate Chief of Medicine, VACT Director of Hypertension, VACT American
More informationCardiovascular Diseases in CKD
1 Cardiovascular Diseases in CKD Hung-Chun Chen, MD, PhD. Kaohsiung Medical University Taiwan Society of Nephrology 1 2 High Prevalence of CVD in CKD & ESRD Foley RN et al, AJKD 1998; 32(suppl 3):S112-9
More informationAssessment and Management of Hypertension in Patients on Dialysis
Assessment and Management of Hypertension in Patients on Dialysis Rajiv Agarwal,* Joseph Flynn, Velvie Pogue, Mahboob Rahman, Efrain Reisin, and Matthew R. Weir *Division of Nephrology, Department of Medicine,
More informationUNIVERSITY OF CALGARY. Blood Volume Monitoring Guided Ultrafiltration Biofeedback on the Reduction of
UNIVERSITY OF CALGARY Blood Volume Monitoring Guided Ultrafiltration Biofeedback on the Reduction of Intradialytic Hypotensive Episodes in Hemodialysis by Kelvin Cheuk-Wai Leung A THESIS SUBMITTED TO THE
More informationOCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA
OMED 17 OCTOBER 7-10 PHILADELPHIA, PENNSYLVANIA 29.5 Category 1-A CME credits anticipated ACOFP / AOA s 122 nd Annual Osteopathic Medical Conference & Exposition ACOFP - The Heart of the Matter - An Evidence
More informationClinical judgment is the most important element in overhydration assessment of chronic hemodialysis patients
Clin Exp Nephrol (2013) 17:563 568 DOI 10.1007/s10157-012-0745-9 ORIGINAL ARTICLE Clinical judgment is the most important element in overhydration assessment of chronic hemodialysis patients Radovan Vasko
More informationmorbidity & mortality
morbidity & mortality esrd introduction of ESRD treatment. We examine these concerns throughout the ADR, particularly in Chapter One. This year we focus on infectious complications, especially those related
More informationUnderstanding Kt/V and Volume Control
Understanding Kt/V and Volume Control Its practical use to determine dialysis and improve outcomes Caroline Williams RD May 23, 2017 Volume Control in Dialysis Patients Pathogenesis In the 1960s and early
More informationCardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center
Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD
More informationCASE STUDIES IN ADVANCED HEART FAILURE
CASE STUDIES IN ADVANCED HEART FAILURE Navin Rajagopalan, MD Director, Congestive Heart Failure Medical Director, Cardiac Transplantation Gill Heart Institute, Cardiovascular Medicine DISCLOSURES NOTHING
More informationChallenges to Manage Blood Pressure in ESRD and Heart Failure Patients
Challenges to Manage Blood Pressure in ESRD and Heart Failure Patients Shweta Bansal, MD, FASN Associate Professor of Medicine UT Health San Antonio 2nd Annual Cardiorenal Connections Meeting, April 28,
More informationNatriuretic Peptides The Cardiologists View. Christopher defilippi, MD University of Maryland Baltimore, MD, USA
Natriuretic Peptides The Cardiologists View Christopher defilippi, MD University of Maryland Baltimore, MD, USA Disclosures Research support: Alere, BG Medicine, Critical Diagnostics, Roche Diagnostics,
More informationCardiovascular Risk Reduction in Kidney Transplant Recipients
Cardiovascular Risk Reduction in Kidney Transplant Recipients Rainer Oberbauer R.O. AUG 2010 CV Mortality in ESRD compared to the general population R.O.2/32 Modified from Foley et al. AJKD 32 (suppl3):
More informationUniversity of Groningen
University of Groningen Effects of relative blood volume-controlled hemodialysis on blood pressure and volume status in hypertensive patients Dasselaar, J.J.; Huisman, R.M.; De Jong, P.E.; Burgerhof, J.G.M.;
More informationHow to deal with hypotension on dialysis? CME Basics in Nephrology SGN-SSN Interlaken 2016
How to deal with hypotension on dialysis? CME Basics in Nephrology SGN-SSN Interlaken 2016 PD Dr. med. Andreas Kistler Leitender Arzt Nephrologie und Dialyse Kantonsspital Frauenfeld www.spital-thurgau.ch
More informationUsing Lung Ultrasound to Diagnose and Manage Acute Heart Failure
Using Lung Ultrasound to Diagnose and Manage Acute Heart Failure Jennifer Martindale, MD Assistant Professor Department of Emergency Medicine SUNY Downstate/Kings County Hospital Brooklyn, NY What is acute
More informationMechanisms and Treatment of Intradialytic Hypertension
Review Advances in CKD 2016 Published online: January 15, 2016 Peter Noel Van Buren a Jula K. Inrig b a University of Texas Southwestern Medical Center, Department of Internal Medicine and Division of
More informationWhy Consider Home Dialysis? Empower the patient!
Why Consider Home Dialysis? Empower the patient! Michael Kraus, MD FACP Professor of Clinical Medicine Indiana University School of Medicine Arguments against increased frequency home dialysis 1. Too small
More informationImportance of Ambulatory Blood Pressure Monitoring in Adolescents
Importance of Ambulatory Blood Pressure Monitoring in Adolescents Josep Redon, MD, PhD, FAHA Internal Medicine Hospital Clinico Universitario de Valencia University of Valencia CIBERObn Instituto de Salud
More informationLa relation dialyse et nutrition
Nutrition en dialyse : controverses La relation dialyse et nutrition Charles Chazot, MD NephroCare Tassin-Charcot Sainte Foy Les Lyon, France HEMO study lessons (1) Dose Body weight flux Rocco, Kidney
More informationNoor Naif Al-Hakami. Pharm-D candidate (KSU)
Hypertension In Hemodialysis Patients Treated With Atenolol Or Lisinopril: A Randomized Controlled Trial (Rajiv Agarwal, Arjun D. Sinha, Maria K. Pappas, Terri N. Abraham and Getachew G. Tegegne ) Noor
More informationWHEN (AND WHEN NOT) TO START DIALYSIS. Shahid Chandna, Ken Farrington
WHEN (AND WHEN NOT) TO START DIALYSIS Shahid Chandna, Ken Farrington Changing Perspectives Beta blockers 1980s Contraindicated in heart failure Now mainstay of therapy HRT 1990s must Now only if you have
More informationOnline HD monitoring (BVM, OCM, BTM, etc.): Useful tools or fancy toys?
Online HD monitoring (BVM, OCM, BTM, etc.): Useful tools or fancy toys? Patrice Ambühl Basics in SSN/SGN Meeting, December 4 2013 patrice.ambuehl@waid.zuerich.ch Nephrologie Therapeutical dilemma Ultrafiltra
More informationKrediet slide di 18
1 di 18 Assessment of fluid status in PD patients Raymond T. Krediet, Amsterdam, Netherlands Chairs:Walther H. Boer, Utrecht, The Netherlands F. Fevzi Ersoy, Antalya, Turkey Prof. Raymond T. Krediet DDivision
More informationWhich dialysis unit blood pressure is the most accurate for predicting home blood pressure in patients undergoing hemodialysis?
ORIGINAL ARTICLE Korean J Intern Med 2017;32:117-124 Which dialysis unit blood pressure is the most accurate for predicting home blood pressure in patients undergoing hemodialysis? In-Cheol Yoon, Hye-Min
More informationMETABOLISM AND NUTRITION WITH PD OBESITY. Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle
METABOLISM AND NUTRITION WITH PD OBESITY Rajnish Mehrotra Harborview Medical Center University of Washington, Seattle 1 Body Size in Patients New to Dialysis United States Body Mass Index, kg/m2 33 31
More informationMonitoring Volume Status Using Bioelectrical Impedance Analysis in Chronic Hemodialysis Patients
ASAIO Journal 2017 Renal/Extracorporeal Blood Treatment Monitoring Volume Status Using Bioelectrical Impedance Analysis in Chronic Hemodialysis Patients CHAE RIM KIM, JUNG-HO SHIN, JIN HO HWANG, AND SU
More informationStatus of the CKD and ESRD treatment: Growth, Care, Disparities
Status of the CKD and ESRD treatment: Growth, Care, Disparities United States Renal Data System Coordinating Center An J. Collins, MD FACP Director USRDS Coordinating Center Robert Foley, MB Co-investigator
More informationVolume control in maintenance hemodialysis: how to keep your patient dry? Dr. Luc Radermacher
Volume control in maintenance hemodialysis: how to keep your patient dry? Dr. Luc Radermacher Fluid balance in HD Weight HD HD HD Hypervolaemia DW Euvolaemia Hypovolaemia Mo Tu We Th Fr Sa Su Mo Chonic
More informationAetiology versus Prediction - correct for Confounding? Friedo Dekker ERA-EDTA Registry / LUMC
Aetiology versus Prediction - correct for Confounding? Friedo Dekker ERA-EDTA Registry / LUMC Aetiology Study effect of a risk factor on an outcome Consider potential confounding: other risk factor for
More informationEffects of Kidney Disease on Cardiovascular Morbidity and Mortality
Effects of Kidney Disease on Cardiovascular Morbidity and Mortality Joachim H. Ix, MD, MAS Assistant Professor in Residence Division of Nephrology University of California San Diego, and Veterans Affairs
More informationAll patients suitable for home dialysis should do PD first
All patients suitable for home dialysis should do PD first 2008 BC Nephrology Day Conference October 2, 2008 Vancouver, British Columbia Robert S. Lockridge, Jr. M.D. Lynchburg Nephrology Physicians Associate
More informationThe association of body mass index (BMI) with mortality
Body Mass Index-Mortality Paradox in Hemodialysis Can It Be Explained by Blood Pressure? Rajiv Agarwal See Editorial Commentary, pp 989 990 Abstract Unlike the general population, among hemodialysis patients
More informationPredicting and changing the future for people with CKD
Predicting and changing the future for people with CKD I. David Weiner, M.D. Co-holder, C. Craig and Audrae Tisher Chair in Nephrology Professor of Medicine and Physiology and Functional Genomics University
More informationHFpEF, Mito or Realidad?
HFpEF, Mito or Realidad? Ileana L. Piña, MD, MPH Professor of Medicine and Epidemiology/Population Health Associate Chief for Academic Affairs -- Cardiology Montefiore-Einstein Medical Center Bronx, NY
More informationVolume Management 2/25/2017. Disclosures statement: Objectives. To discuss evaluation of hypervolemia in peritoneal dialysis patients
Volume Management Sagar Nigwekar MD, MMSc Massachusetts General Hospital E-mail: snigwekar@mgh.harvard.edu March 14, 2017 Disclosures statement: Consultant: Allena, Becker Professional Education Grant
More informationThe comparative evaluation of patients body dry weight under hemodialysis using two methods: Bioelectrical impedance analysis and conventional method
Original Article The comparative evaluation of patients body dry weight under hemodialysis using two methods: Bioelectrical impedance analysis and conventional method Neda Alijanian 1, Afsoon Emami Naini
More informationSodium elimination and dialysate sodium. How much? Does it matter?
Sodium elimination and dialysate sodium How much? Does it matter? A. Bock Nephrologie Dialysis visit Aarau 3.12.2013 90 kg dialysis patient: 5 kg over dry weight Recent dyspnea. Minimal leg edema RBV in
More informationEchocardiography analysis in renal transplant recipients
Original Research Article Echocardiography analysis in renal transplant recipients S.A.K. Noor Mohamed 1*, Edwin Fernando 2, 1 Assistant Professor, 2 Professor Department of Nephrology, Govt. Stanley Medical
More informationHEART FAILURE IN WOMEN. Marian Limacher, MD Division of Cardiovascular Medicine University of Florida
HEART FAILURE IN WOMEN Marian Limacher, MD Division of Cardiovascular Medicine University of Florida Outline Epidemiology Clinical Overview Why HF is such a challenge State of the Field Heart Failure Adjudication
More informationDIASTOLOGY DON T BE SUCH A STIFF
DIASTOLOGY DON T BE SUCH A STIFF Michael Mallin, MD University of Utah Director Emergency Ultrasound www.ultrasoundpodcast.com Warning: The education found within this presentation is not approved by anyone
More informationAssessment of Fluid Shifts of Body Compartments using Both Bioimpedance Analysis and Blood Volume Monitoring
J Korean Med Sci 2006; 21: 75- ISSN 1011-8934 Copyright The Korean Academy of Medical Sciences Assessment of Fluid Shifts of Body Compartments using Both Bioimpedance Analysis and Blood Volume Monitoring
More informationWebEx Quick Reference
Session 2 Drs. Alvin Moss & David Weissman WebEx Quick Reference Welcome to today s session! Please use Chat to All Raise your hand Participants for questions For technology issues only, please Chat to
More informationThe earlier BP control the better cardiovascular outcome. Jin Oh Na Cardiovascular center Korea University Medical College
The earlier BP control the better cardiovascular outcome Jin Oh Na Cardiovascular center Korea University Medical College Index Introduction HOPE-3 Trial Sprint Study Summary Each 2 mmhg decrease in SBP
More informationHemodialysis. Volume-Associated Ambulatory Blood Pressure Patterns in Hemodialysis Patients. Rajiv Agarwal
Hemodialysis Volume-Associated Ambulatory Blood Pressure Patterns in Hemodialysis Patients Rajiv Agarwal Abstract Although volume excess causes hypertension, whether it also affects circadian patterns
More informationAssessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line
Kidney International, Vol. 68 (25), pp. 854 861 Assessment of dry weight by monitoring changes in blood volume during hemodialysis using Crit-Line HECTOR J. RODRIGUEZ,REGINA DOMENICI,ANNE DIROLL, and IRINA
More informationEPIDEMIOLOGY OF ARRHYTHMIAS AND OUTCOMES IN CKD & DIALYSIS KDIGO. Wolfgang C. Winkelmayer, MD, ScD Baylor College of Medicine Houston, Texas
EPIDEMIOLOGY OF ARRHYTHMIAS AND OUTCOMES IN CKD & DIALYSIS Wolfgang C. Winkelmayer, MD, ScD Baylor College of Medicine Houston, Texas Disclosure of Interests AstraZeneca (scientific advisory board) Bayer
More informationVariable Included. Excluded. Included. Excluded
Table S1. Baseline characteristics of patients included in the analysis and those excluded patients because of missing baseline serumj bicarbonate levels, stratified by dialysis modality. Variable HD patients
More informationChapter six Outcomes: hospitalization & mortality. There is an element of death in life, and I am astonished
INTRODUCTION 1 OVERALL HOSPITALIZATION & MORTALITY 1 hospital admissions & days, by primary diagnosis & patient vintage five-year survival mortality rates, by patient vintage expected remaining lifetimes
More informationTrial to Reduce. Aranesp* Therapy. Cardiovascular Events with
Trial to Reduce Cardiovascular Events with Aranesp* Therapy John J.V. McMurray, Hajime Uno, Petr Jarolim, Akshay S. Desai, Dick de Zeeuw, Kai-Uwe Eckardt, Peter Ivanovich, Andrew S. Levey, Eldrin F. Lewis,
More informationDATE: 25 August 2015 CONTEXT AND POLICY ISSUES
TITLE: Bioimpedance Devices for the Assessment of Body Fluid Volume for Patients Undergoing Dialysis: A Review of the Clinical Effectiveness, Cost-Effectiveness and Guidelines An Update DATE: 25 August
More informationNutritional Cases with CKD HEMODIALYSIS
Nutritional Cases with CKD HEMODIALYSIS S. Muge DEGER, MD, FISN Yuksek Ihtisas University Faculty of Medicine, Koru Hospital Department of Nephrology Ankara, TURKEY CASE-1 BC, is a 60- year- old Caucasian
More informationLow Blood Pressure During Dialysis (Intradialytic Hypotension (IDH))
Low Blood Pressure During Dialysis (Intradialytic Hypotension (IDH)) By Dori Schatell, Medical Education Institute One of the main jobs of dialysis is to remove excess water from your body. Seems pretty
More informationCardiorenal and Renocardiac Syndrome
And Renocardiac Syndrome A Vicious Cycle Cardiorenal and Renocardiac Syndrome Type 1 (acute) Acute HF results in acute kidney injury Type 2 Chronic cardiac dysfunction (eg, chronic HF) causes progressive
More informationAspetti nutrizionali nel paziente in emodialisi cronica
Aspetti nutrizionali nel paziente in emodialisi cronica Enrico Fiaccadori enrico.fiaccadori@unipr.it Università degli Studi di Parma Agenda Diagnosis of protein-energy wasting (PEW) in ESRD on HD Epidemiology
More informationPearls in Acute Heart Failure Management
Pearls in Acute Heart Failure Management Best Practices Juan M. Aranda Jr., M.D. Professor of Medicine Medical Director of Heart Failure/ Transplant Program University of Florida College of Medicine Disclosures:
More informationAssessment of Dry Weight in Hemodialysis: An Overview
REVIEW J Am Soc Nephrol 10: 392 403, 1999 Assessment of Dry Weight in Hemodialysis: An Overview JACK Q. JAEGER and RAVINDRA L. MEHTA Division of Nephrology, Department of Medicine, University of California,
More informationHYPERTENSION AND HEART FAILURE
HYPERTENSION AND HEART FAILURE Kenya Cardiac Society Symposium Feb 2017 Dr Jeilan Mohamed No conflict of interests . Geoffrey, 45 yr old hypertensive office worker male from Nairobi, has just watched his
More information1. Albuminuria an early sign of glomerular damage and renal disease. albuminuria
1. Albuminuria an early sign of glomerular damage and renal disease albuminuria Cardio-renal continuum REGRESS Target organ damage Asymptomatic CKD New risk factors Atherosclerosis Target organ damage
More informationCJASN epress. Published on May 27, 2010 as doi: /CJN
Original Articles CJASN epress. Published on May 27, 2010 as doi: 10.2215/CJN.01760210 Dry-Weight: A Concept Revisited in an Effort to Avoid Medication-Directed Approaches for Blood Pressure Control in
More informationTreating Hypertension in 2018: What Makes the Most Sense Today?
Treating Hypertension in 2018: What Makes the Most Sense Today? Daniel Blanchard, MD Professor of Medicine UC San Diego Cardiovascular Center La Jolla, California 1 2 Speaker Disclosures Consultant and/or
More informationEffects of heart rate reduction with ivabradine on left ventricular remodeling and function:
Systolic Heart failure treatment with the If inhibitor ivabradine Trial Effects of heart rate reduction with ivabradine on left ventricular remodeling and function: results of the SHIFT echocardiography
More informationOlistic Approach to Treatment Adequacy in AKI
Toronto - Canada, 2014 Olistic Approach to Treatment Adequacy in AKI Claudio Ronco, MD Department of Nephrology, St. Bortolo Hospital, International Renal Research Institute Vicenza - Italy 1) RRT
More informationHeart Failure Guidelines For your Daily Practice
Heart Failure Guidelines For your Daily Practice Juan M. Aranda, Jr., MD, FACC, FHFSA Professor of Medicine Director of Heart Failure and Cardiac Transplantation University of Florida College of Medicine
More informationArches National Park, Utah. hospitalization
Arches National Park, Utah 237 212 USRDS annual data report 2volume 238 24 overall 242 re 244 admission rates by interdialytic interval 246 summary Remote from universal nature and living by complicated
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Advances in Management of Robert B. Baron MD Professor of Medicine Associate Dean for GME and CME Declaration of full disclosure: No conflict of interest Current Status of Prevalence 29%; Blacks 33.5%
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationKDIGO LESSONS LEARNED FROM NEPHROLOGY TRIALS WITH RESPECT TO HEART FAILURE
LESSONS LEARNED FROM NEPHROLOGY TRIALS WITH RESPECT TO HEART FAILURE Dr. Christopher T Chan Director Division of Nephrology University Health Network Professor of Medicine University of Toronto Disclosure
More informationDialysis Dose and Body Mass Index Are Strongly Associated with Survival in Hemodialysis Patients
J Am Soc Nephrol 13: 1061 1066, 2002 Dialysis Dose and Body Mass Index Are Strongly Associated with Survival in Hemodialysis Patients FRIEDRICH K. PORT, VALARIE B. ASHBY, RAJNISH K. DHINGRA, ERIK C. ROYS,
More informationADVANCES IN MANAGEMENT OF HYPERTENSION
Prevalence 29%; Blacks 33.5% About 72.5% treated; 53.5% uncontrolled (>140/90) Risk for poor control: Latinos, Blacks, age 18-44 and 80,
More informationDiagnostic Utility of Blood Volume Monitoring in Hemodialysis Patients
Diagnostic Utility of Blood Volume Monitoring in Hemodialysis Patients Rajiv Agarwal, MD, 1,2 Ken Kelley, PhD, 3 and Robert P. Light, BS 1,2 Background: Assessment of volume state is difficult in hemodialysis
More informationBlood Pressure Measurement in SPRINT
Blood Pressure Measurement in SPRINT Karen C. Johnson, MD, MPH, FAHA Vice Chair, SPRINT Steering Committee University of Tennessee Health Science Center, Department of Preventive Medicine For the SPRINT
More informationRecognizing and Treating Patients with the Cardio-Renal Syndrome
Recognizing and Treating Patients with the Cardio-Renal Syndrome Joachim H. Ix, MD, MAS, FASN Professor of Medicine Chief; Division of Nephrology-Hypertension University of California San Diego 1 Conflicts
More informationPlasma MR-proADM is superior to NTproBNP for all-cause short term mortality prediction in acute pulmonary embolism.
J. Pedowska-Wloszek, M. Kostrubiec, A. Labyk, S. Pacho, O. Dzikowska-Diduch, P. Bienias, B. Lichodziejewska, P. Palczewski, M. Ciurzynski, P. Pruszczyk Plasma MR-proADM is superior to NTproBNP for all-cause
More informationYasushi Ohashi, MD, Takatoshi Otani, MD, Reibin Tai, MD, Yoshihide Tanaka, MD, Ken Sakai, MD, PhD, and Atsushi Aikawa, MD, PhD
RESEARCH BRIEF Assessment of Body Composition Using Dry Mass Index and Ratio of Total Body Water to Estimated Volume Based on Bioelectrical Impedance Analysis in Chronic Kidney Disease Patients Yasushi
More informationPlasma sodium as a predictor of death and non-osmotic sodium storage
An update on sodium in CKD stage 5D Plasma sodium as a predictor of death and non-osmotic sodium storage Prof. Mustafa ARICI, MD Hacettepe University Faculty of Medicine Ankara-TURKEY 2 (new) questions...
More informationAttending Rounds. Attending Rounds: A Patient with Intradialytic Hypotension
Attending Rounds Attending Rounds: A Patient with Intradialytic Hypotension Robert F. Reilly Abstract Intradialytic hypotension is the most common adverse event that occurs during the hemodialysis procedure.
More informationUniversity of Padova, Padua, Italy, and HARVEST Study Group, Italy
University of Padova, Padua, Italy, and HARVEST Study Group, Italy ISOLATED SYSTOLIC HYPERTENSION IN THE YOUNG DOES NOT IMPLY AN INCREASED RISK OF FUTURE HYPERTENSION NEEDING TREATMENT Mos L, Saladini
More informationYou can sleep while I dialyze
You can sleep while I dialyze Nocturnal Peritoneal Dialysis Dr. Suneet Singh Medical Director, PD, VGH Division of Nephrology University of British Columbia Acknowledgements Melissa Etheridge You can sleep
More informationDEFINITIONS FOR FLUID STATUS & TARGET WEIGHT
Home Dialysis Interest Group HEALTHCARE TEAM TOOL DEFINITIONS FOR STATUS & TARGET WEIGHT BALANCED EXCESS DEFICIT Illustrations provided by: 1 BALANCE OF THE HOME HEMODIALYSIS PATIENT Dialysis Weight**
More informationTreating hypertension in kidney transplant recipients
Treating hypertension in kidney transplant recipients Mark Mitsnefes, MD, MS Professor of Pediatrics Director, Clinical Translational Research Center Cincinnati Children s Hospital Medical Center University
More informationHEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS 1.0 PRACTICE CONSIDERATIONS 2.0 CURRENT LITERATURE REVIEW
HEMODIALFILTRATION LITERATURE REVIEW AND PRACTICE CONSIDERATIONS This document was prepared at the request of the BC Hemodialysis Committee to provide a brief overview of the literature and to identify
More informationNearly 40 years ago, when dialysis was still in its
Dry-Weight: A Concept Revisited in an Effort to Avoid Medication-Directed Approaches for Blood Pressure Control in Hemodialysis Patients Rajiv Agarwal* and Matthew R. Weir *Indiana University School of
More informationOptimal blood pressure targets in chronic kidney disease
Optimal blood pressure targets in chronic kidney disease Pr. Michel Burnier Service of Nephrology and Hypertension University Hospital Lausanne Switzerland Evidence-Based Guideline for the Management
More information9/14/2017 HEART FAILURE IN OBS NO RELEVANT DISCLOSURES IRRELEVANT DISCLOSURES OBJECTIVES WHY HEART FAILURE
HEART FAILURE IN OBS Matthew Wheatley MD, FACEP Grady Memorial Hospital Emory University School of Medicine NO RELEVANT DISCLOSURES 52 y.o. female with HTN, DM and CHF presents with DIB. She states she
More information